SHLP-2 Research for Age-Related Macular Degeneration
An evidence-based overview of research examining SHLP-2 in the context of age-related macular degeneration. This page synthesizes findings from peer-reviewed literature.
Research Summary
In vitro studies using retinal pigment epithelium cells from AMD patients showed SHLP-2 improved mitochondrial function, increased mtDNA copy numbers, and enhanced PGC-1a expression. These findings suggest potential for mitochondrial-targeted AMD therapy, but remain limited to cell culture models.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. SHLP-2 has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.